agilon health, inc. (NYSE: AGL) had its "sell" rating re-affirmed by analysts at Citigroup Inc.. They now have a $2.50 price target on the stock, down previously from $7.00.
agilon health, inc. (AGL)
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
AGL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AGL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AGL alerts
High impacting agilon health, inc. news events
Weekly update
A roundup of the hottest topics
AGL
News
- AGILON ALERT: Bragar Eagel & Squire, P.C. is Investigating Agilon Health, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmGlobeNewswire
- AGILON HEALTH INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of agilon health, inc. - AGLBusiness Wire
- agilon health Sets Date to Report Third Quarter 2024 Financial ResultsBusiness Wire
- AGILON HEALTH INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of agilon health, inc. - AGLPR Newswire
- agilon health, inc. (NYSE: AGL) had its price target lowered by analysts at Evercore ISI from $7.00 to $4.00. They now have an "in-line" rating on the stock.MarketBeat
AGL
Earnings
- 8/6/24 - In-Line
AGL
Sec Filings
- 10/24/24 - Form SC
- 9/16/24 - Form 4
- 9/10/24 - Form SC
- AGL's page on the SEC website